Physician profile
Allison Stevens
NPI 1265986319
$2,360.54
in general payments reported to CMS, 2019-2025
26 companies · $1,080 in 2025
The $1,080 reported for 2025 was more than what 86% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79.63 · 2022: $229 · 2023: $282 · 2024: $691 · 2025: $1,080.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,052.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,052.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $319.85 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $246.64 | 2023-2025 | Verquvo, Belsomra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.09 | 2021-2025 | Jardiance |
| Novo Nordisk INC | $192.83 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Edwards Lifesciences Corporation | $180.94 | 2025 | Sapien 3 Ultra Resilia |
| Scpharmaceuticals INC. | $160.41 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $117.97 | 2021-2025 | Farxiga |
| Actelion Pharmaceuticals US, INC. | $112.46 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Lilly USA, LLC | $91.80 | 2022-2025 | Mounjaro, Zepbound |
| Amgen INC. | $88.54 | 2022-2025 | Repatha, Prolia, Evenity |
| Exact Sciences Corporation | $87.68 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $78.26 | 2023-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $71.63 | 2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $63.33 | 2024-2025 | Optimizer |
| Esperion Therapeutics, INC. | $56.30 | 2024-2025 | Nexletol |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $46.17 | 2025 | Symphony Catheter |
| Pfizer INC. | $34.75 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $32.90 | 2024 | Camzyos |
| Baxter Healthcare | $27.32 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Amarin Pharma, INC. | $21.77 | 2021 | |
| Vanda Pharmaceuticals INC. | $21.70 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.29 | 2022 | |
| Idorsia Pharmaceuticals US INC | $18.05 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $14.39 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $13.28 | 2024 | Assure Wcd |
| Phathom Pharmaceuticals, INC. | $11.19 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.